March 15, 2026 expert reaction to conference abstract comparing prostate cancer and breast cancer screening programmes, being presented at the European Association of Urology Cong ...
Cancer cases are rising worldwide, with health experts warning that millions of new diagnoses each year are placing growing pressure on health systems, ...
In a randomised trial, men who experience premature ejaculation benefitted from using an app to learn techniques for extending intercourse ...
Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are ...
The Melonga App guides users through a number of therapeutic techniques, tips and exercises designed by urologists and ...
UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.
Morning Overview on MSN
New prostate cancer immunotherapy cuts biomarkers by up to 99% in trial
A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced ...
Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results